Sort
30,917 grants matching “tumor microenvironment”
Exploring the Role of Nitrogen Metabolism in Cancer
$926,340Craig B Thompson · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$925,900Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Stromal Regulation of Bone Metastasis
$925,878Raghu Kalluri · Beth Israel Deaconess Medical Center · U54 · FY2011 · CA
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$925,385Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2025 · CA
Role of the microbiota in regulating the mononuclear phagocyte system
$925,047Silvana Goldszmid · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Identification of Cooperative Genetic Alterations in the Pathogenesis of Oral Cancer
$924,971John B Sunwoo · Stanford University · U01 · FY2017 · DE
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$924,682Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Integrating tumor and stroma to understand and predict treatment response
$924,643Jen Jen Yeh · Univ Of North Carolina Chapel Hill · U01 · FY2023 · CA
Overcoming resistance to anti-PD1 immunotherapy
$924,579Thomas F Gajewski · University Of Chicago · R35 · FY2022 · CA
Defining and Exploiting the Neuronal Identity of Cancers
$924,560Madeleine Julie Oudin · Tufts University Medford · DP2 · FY2024 · CA
Metabolic Regulators of Tumor Growth and Progression
$924,299Ralph J Deberardinis · Ut Southwestern Medical Center · R35 · FY2022 · CA
Drug candidates that disrupt the NEMO/IKK signaling complex for the treatment of
$924,148Stig K. Hansen · Carmot Therapeutics, Inc. · R44 · FY2014 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$924,071Ronald Levy · Stanford University · R35 · FY2016 · CA
Signal Transduction Events and the Regulation of Cell Growth
$923,994Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2019 · CA
Advancing Cancer Therapy through Ground Breaking Research in Radiation Biology
$923,949David G Kirsch · Duke University · R35 · FY2022 · CA
Towards a quantitative understanding of tumor evolution
$923,400Raul Rabadan · Columbia University Health Sciences · R35 · FY2024 · CA
Exploring DNA damage response pathways as targets for cancer therapy
$923,400Junjie Chen · University Of Tx Md Anderson Can Ctr · R35 · FY2024 · CA
Omic and Multidimensional Spatial Atlas of Metastatic Breast Cancer
$923,254Emek Demir · Oregon Health & Science University · U2C · FY2023 · CA
R&D- MEDICAL: BIOMEDICAL (BASIC RESEARCH)
$922,642Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2016 · CA
Molecular and immunologic evolution of melanomas from pre-neoplastic lesions
$922,472Boris C Bastian · University Of California, San Francisco · R35 · FY2019 · CA
Role of inflammation in epigenetic alterations of metastatic cancer cells
$922,232Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Host immature myeloid cells in tumor suppressor or promoter roles of TGFbeta
$922,232Li Yang · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Regulatory T cells and the tumor microenvironment
$921,907Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · R35 · FY2025 · CA
Neuroblastoma Tumor Microenvironment: tumor growth and immune regulation
$921,619Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$921,373Margie Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA